VCMCVC Market Cap
Menu

Funding round

PharmEasy Series C

PharmEasy, which works in digital healthcare platform services in Mumbai, raised $50M in a Series C round announced on 26 Sep 2018, led by Eight Roads. 6 firms took part. It is PharmEasy's third venture round on record; the one before was a Series B in Apr 2017.

PharmEasy Unconfirmed

$50M

Amount raised

Not disclosed

Post-money valuation

6

Investors

1 lead

Valuation

What this round says about the price

PharmEasy did not disclose a valuation in this round. It came 17 months after PharmEasy's Series B. It is 5.8% of the $858M PharmEasy has raised in the venture rounds on record. PharmEasy raised again 14 months later: a Growth round of $220M in Nov 2019. Its next priced round, a Series E in Apr 2021, valued it at $1.50B.

PharmEasy's funding rounds

PharmEasy has 6 venture rounds on record and 2 other deals. This one is highlighted.

  1. Series A 1 Jan 2016, led by Bessemer Venture Partners $5.0M
  2. Series B 3 Apr 2017, led by Bessemer Venture Partners and Orios Venture Partners $17M
  3. Series C this round 26 Sep 2018, led by Eight Roads $50M
  4. Debt not a venture round 27 Sep 2018 $5.5M
  5. Growth 27 Nov 2019 $220M
  6. Series E 7 Apr 2021, led by Prosus Ventures and TPG $350M$1.50B post-money
  7. Growth 30 Apr 2024, led by Manipal Education and Medical Group $216M$710M post-money
  8. Debt not a venture round 1 Sep 2025, led by 360 One $193M

Investors

Who put money in

Eight Roads led the round with 5 other firms.

Lead investor

  • backs 125 venture-backed companies new investor

Also in the round

  • backs 118 venture-backed companies new investor
  • backs 11 venture-backed companies new investor
  • backs 16 venture-backed companies new investor
  • Bessemer Venture Partners backs 412 venture-backed companies new investor
  • Fidelity International Ltd new investor

Use of proceeds

What the money is for

According to the announcement, the money goes to hiring, product development, geographic expansion, sales and marketing, scaling operations and working capital.

  • Hiring
  • Product development
  • Geographic expansion
  • Sales and marketing
  • Scaling operations
  • Working capital

Comparable rounds

How it compares

The closest in time, other companies' Series C rounds in Drug Stores & Pharmacies:

Comparable rounds
CompanyAnnouncedAmountPost-moneyLed by
Alto Pharmacy Drug Stores & Pharmacies5 Dec 2018$50Mnot disclosednot named
Fuze Health Drug Stores & Pharmacies5 Dec 2018$50Mnot disclosedZola Global and Greenoaks
Drug Stores & Pharmacies28 Jan 2019$100M$1.00BGrowth-stage investor
Capsule Drug Stores & Pharmacies30 Sep 2019$200Mnot disclosedTechnology Crossover Ventures

Sources

Where this comes from

Reported by 3 sources. The deal data marks this round as not yet confirmed by an official announcement. Unconfirmed

Questions

Frequently asked

How much did PharmEasy raise in its Series C round?

PharmEasy raised $50M in its Series C round, announced in Sep 2018.

Who led PharmEasy's Series C round?

Eight Roads led it, with F-Prime Capital, Fundamentum, Think Investments, Bessemer Venture Partners and Fidelity International Ltd.

What was PharmEasy's valuation at the Series C round?

It was not disclosed.

Did PharmEasy raise again after this round?

Yes: a Growth round in Nov 2019 of $220M.